Comments on: Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease

Comments on: Liver Complications Lead FDA to Stop Tests of Intellia Gene-Editing Therapy for a Rare Disease https://medcitynews.com/2025/10/intellia-gene-editing-therapy-fda-clinical-hold-crispr-rare-disease-attr-ntla/ Healthcare technology news, life science current events Fri, 31 Oct 2025 22:17:59 +0000 hourly 1 https://wordpress.org/?v=6.8.5